Logo of Saudi Pharmaceutical Industries & Medical Appliances Corp. (SPIMACO)
Saudi Pharmaceutical Industries & Medical Appliances Corp.’s (SPIMACO) shareholders will vote on utilizing SAR 34.71 million in consensual reserve and SAR 150 million from the general reserve balance to fully amortize the SAR 124.36 million worth of accumulated losses (10.36% of capital), during the extraordinary general meeting (EGM) to be held on Nov. 14.
The abovementioned accumulated losses are as in the financial statements for the period ended March 31, 2023, the company said in a Tadawul statement today, Oct. 23.
Other agenda items include deciding on the company’s long-term incentive program (LTIP) for employees and authorizing the board of directors to determine the terms of this program, including the allocation price for each share offered to employees if it is for consideration.
The EGM will also vote on the repurchase of a maximum of 815,000 shares to be allocated to the program. The buyback will be financed from SPIMACO’s cash flow. The board will be authorized to complete the repurchase in 12 months maximum from the EGM date, the statement added.
The company may hold the repurchased shares for no more than four years from the EGM date until they are allotted to the LTIP. After this, the company shall follow the requirements stipulated in the relevant laws and regulations.
Comments
{{DisplayName}}
{{ElapsedTime}}